Skip to main content

Advertisement

Figure 3 | BMC Medicine

Figure 3

From: Prescriber and patient-oriented behavioural interventions to improve use of malaria rapid diagnostic tests in Tanzania: facility-based cluster randomised trial

Figure 3

Flow chart defining the primary outcome and showing prescribing practices. Fever status not known for 40 patients in the control arm, 14 in the HW arm and 6 in the HWP arm. Of these patients, five (13%) in the control, four (29%) in the HW arm and three (50%) in the HWP arm also had alternate diagnosis missing. Data on whether or not they had an RDT and the result is known for all patients with missing fever status but are not included in the analysis. Obvious alternate diagnosis (soft tissue, ear or urine infection) not known for four patients in each arm among those with a history of fever, and one in the control arm and five in the HW arm for those with no history of fever. Data on whether or not they had an RDT (and the result) is known for all these patients but are not included in the analysis. Whether or not an RDT was taken is unknown for one patient in the control arm. # RDT result is unknown for 77 (1%) in the control arm, 94 (1%) in the HW arm and 92 (2%) in the HWP arm. Recommended antimalarial (rAM) defined as quinine for children under 2 months, Artemether Lumefantrine (ALu) or quinine for women of childbearing age, and ALu for all others. Abx represents antibiotics; HW, health worker; HWP, health worker plus patient-oriented; RDT, rapid diagnostic test.

Back to article page